Stratos Genomics
AcquiredStratos Genomics developed Sequencing By Expansion (SBX) technology for DNA sequencing applications.
Facts
- HQ
- Seattle, WA, US
- Sectors
- Biotechnology, Genomics, DNA sequencing
- Status
- Acquired (May 2020)
- Stage
- former-startup
- Members see funding amounts. .
Is this your organization? Claim it
Roche acquires Seattle startup Stratos Genomics, home of Sequencing By Expansion, to form Roche Diagnostics Seattle
Roche has acquired Seattle DNA sequencing startup Stratos Genomics, maker of Sequencing By Expansion (SBX) technology; Stratos will operate as Roche Diagnostics Seattle with its 60 employees joining Roche. Financial terms were not disclosed; Stratos had raised over $60 million previously and Roche was an early investor.
Stratos Genomics raises $20M from Fisk Ventures to commercialize SBX nanopore DNA sequencing, total funding tops $50M
Stratos Genomics raised $20 million from Fisk Ventures to finalize commercialization of its Sequencing By Expansion (SBX) nanopore-based DNA sequencing technology, bringing total funding to over $50 million. The company says SBX is faster, cheaper and highly accurate, aiming to enter healthcare, research, agriculture and biotech markets within the coming year.
People
-
Mark Kokoris Co-founder
Questions about Stratos Genomics
What is Stratos Genomics?
Seattle, WA, US
Who are the people behind Stratos Genomics?
Seattle Flow lists Mark Kokoris (Co-founder) at Stratos Genomics.
Who invested in Stratos Genomics, and how much has it raised?
Members of Seattle Flow see Stratos Genomics' funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Stratos Genomics based?
Stratos Genomics is headquartered in Seattle, WA, US.